See the DrugPatentWatch profile for Polivy
What is the current Polivy (polatuzumab vedotin-piiq) price in the U.S.?
Polivy is a prescription cancer medicine, and its “price” depends on the exact product strength, package size, and the patient’s coverage (commercial insurance, Medicare, Medicaid, or a financial-assistance program). The information provided here does not include any list price, net price, or pharmacy markup details for Polivy, so I can’t give a reliable number without a source.
If you tell me your country (or whether you mean U.S.), and the strength/package size your pharmacy listed, I can help you narrow down what price references typically apply.
How much does Polivy cost per dose or per vial?
Cost per dose is driven by:
- the dose prescribed (mg/kg or fixed calculation based on body weight),
- vial size and the number of vials needed to deliver that dose,
- whether the billing is based on a physician-administered drug claim versus pharmacy retail pricing.
The exact cost-per-dose figure isn’t included in the information available here, so I can’t compute it accurately.
Does Polivy have a patient assistance or copay program that lowers the out-of-pocket cost?
Many specialty oncology drugs offer manufacturer copay assistance (for commercially insured patients) or patient assistance (for eligible uninsured/underinsured patients), and these can substantially reduce what a patient pays. However, no program details are included here, so I can’t confirm eligibility requirements or copay caps.
Are there alternatives to lower the total treatment cost?
Polivy is used in combination regimens. Alternatives and cost differences depend on:
- the treatment line (first-line vs relapsed/refractory),
- the exact regimen chosen by the oncologist,
- whether other options are available as generics/biosimilars (Polivy itself is not a generic in most settings).
I can map cost drivers to alternatives if you share the regimen and your country.
If you’re seeing a “Polivy price” online, why might it not match your bill?
Online prices often differ from what patients actually pay because of:
- wholesale acquisition cost vs negotiated insurer price,
- hospital/infusion center markup and billing practices,
- patient-specific discounts through payer contracts,
- eligibility-based assistance.
Without a cited price source or your bill details, matching your number reliably isn’t possible.
What I need from you to give a useful price answer
Reply with:
1) Your country (and state if U.S.),
2) Strength/package size (e.g., number of vials and mg per vial as printed on the box or invoice),
3) Whether you mean list price, insurance-negotiated cost, or what you personally pay.
Then I can help interpret the figure and identify the most relevant reference point.